VBI Vaccines Competitors and Similar CompaniesClear all

PolyPid's competitors and similar companies include Adaptimmune and CosmosID.

	PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.	CosmosID CosmosID develops softwarefor identifyingpathogens present in clinical, environmental, and other research samples.
Founding Date	Founding Date 2008	Founding Date 2008	Founding Date 2008
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech fitness & wellness healthtech pharma
Locations	Locations Petah Tikva, IL HQ Summit, US	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB	Locations Germantown, US HQ Södertälje, SE
Employees	Employees 57	Employees 4007% decrease	Employees 25
Valuation ($)	Valuation ($) 23.7 m	Valuation ($) 188.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $178m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $70k (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $178m (FY, 2024)	Gross profit N/A
Net income	Net income ($34.2m) (FY, 2025)	Net income ($70.8m) (FY, 2024)	Net income N/A
Operating ⚠
Patent Applications	Patent Applications 49 (FY, 2017)	Patent Applications 69 (FY, 2016)	Patent Applications N/A
Patents Issued	Patents Issued 104 (FY, 2017)	Patents Issued 173 (FY, 2016)	Patents Issued N/A
Funding
Total funding raised	Total funding raised $ 103.8m	Total funding raised $ 107.5m	Total funding raised $ 7.2m